Definitive Contract 75F40122C00071
Award Date
7/20/22
Potential Completion Date
7/21/27
Potential Value
$1.2M
Federal Agency
Food and Drug Administration
Ultimate Awardee
Washington Dept Of Public Inst
NAICS Category
923120 - Administration of Public Health Programs
PSC Category
H265 - Equipment And Materials Testing- Medical, Dental, And Veterinary Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Olympia, WA 98504, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price definitive contract awarded by the Department of Health and Human Services' Food and Drug Administration to the Washington State Department of Health. The contract, valued at $1,631,410.57, is for state mammography inspections services to be performed in Rockville, Maryland. The contract does not have a set-aside designation. The Washington State Department of Health is a U.S. state government entity that provides a range of public health services and has received...
The U.S. Food and Drug Administration (FDA) awarded a $2,482,950.23 Firm Fixed Price contract to the Michigan Department of Labor and Economic Opportunity (MDLEO), doing business as the Talent Investment Agency, to implement the Mammography Quality Standards Act (MQSA). The contract, awarded without any set-aside designation, runs through March 2022 and requires MDLEO to provide specialized regulatory oversight and services to ensure the quality and safety of mammography facilities. As a state...
The Food and Drug Administration (FDA) awarded a $483,881.81 firm-fixed-price definitive contract to the Arkansas Department of Health (ADH) for the "ARKANSAS MQSA INSPECTION CONTRACT". This contract supports inspections of certified non-federal mammography facilities in Arkansas to ensure compliance with the Mammography Quality Standards Act (MQSA). ADH was selected as the sole source provider for this requirement due to its legal authority under state law to access commercial...
This firm-fixed-price contract was awarded by the Food and Drug Administration (FDA) to the Colorado Department of Public Health & Environment (CDPHE), a state government entity, to provide Mammography Quality Standards Act (MQSA) inspections. The contract has a ceiling value of $453,010.00 and a period of performance from March 1, 2003, to February 28, 2006. CDPHE, a subsidiary of the City of Lakewood, has a long history of executing federal contracts and grants across various public health...
This contract was awarded by the Food and Drug Administration (FDA) to the Arizona Department of Health Services (ADHS), a state government entity, to conduct inspections of certified non-federal mammography facilities in Arizona. The contract, valued at $1,911,936.08, is a definitive, firm-fixed-price contract with a period of performance through March 29, 2028. The original solicitation was a sole-source procurement, as the inspections require legal authority under state law and experience...
The Food and Drug Administration (FDA) awarded a definitive, firm-fixed price contract worth $1,573,686.15 to the Alabama Department of Public Health (ADPH) to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). This contract, which has no set-aside designation, runs through March 31, 2028. The original solicitation indicates that the FDA intends to award sole source contracts to...
This is a $1,337,028.39 firm-fixed-price contract awarded by the Food and Drug Administration (FDA) to the Virginia State Board of Health (VA SBOH) for the VA Mammography Quality Standards Act (MQSA) program. The contract, which runs through March 2028, is not set aside for any specific business type. The VA SBOH, a state government entity, will be responsible for ensuring proper equipment, training, and procedures at mammography facilities across Virginia through this contract. The VA SBOH...
<p>The Food and Drug Administration (FDA) awarded a firm fixed price definitive contract to the City of New York, through its New York City Department of Health and Mental Hygiene Division (Health Dept), for the implementation of the Mammography Quality Standards Act (MQSA) in New York City. The contract, valued at $3,676,553.75, has an ultimate completion date of March 29, 2028. The contract was awarded on September 22, 2022 and does not have a set-aside designation.</p>
This is a definitive, firm-fixed-price contract valued at $984,998.12 awarded by the Food and Drug Administration (FDA) to the Department of State Health Services (DSHS), a U.S. state government entity, for MQSA (Mammography Quality Standards Act) inspections. The contract has an ultimate completion date of August 31, 2007 and was awarded on September 1, 2005. This contract does not have a set-aside designation. DSHS is serving as the prime contractor and has an extensive history of executing...
This firm-fixed-price definitive contract was awarded by the Food and Drug Administration (FDA) to the Hawaii Department of Health Children With Special Health Needs - NBS Division, a state government entity, to provide Mammography Quality Standards Act (MQSA) inspection services in Hawaii. The contract has a ceiling value of $210,247.68 and a period of performance through January 15, 2028. This contract is not designated under any set-aside program. The Hawaii Department of Health holds several...